GLSI
Greenwich LifeSciences, Inc. · Healthcare · Market cap $226.8M
Insiders bought $97K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Jul 30, 2026
Insider Buying
$586K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Jul 30, 2026
Patel Snehal
Greenwich LifeSciences, Inc. (GLSI) has 11 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 30, 2026.
Inside the rolling window, 1 insider at Greenwich LifeSciences, Inc. reported 13 open-market purchases totaling $586K and no open-market sales. The most active filer is CEO and CFO Patel Snehal with 13 filings. The most recent open-market filing is a purchase of 1,500 shares by CEO and CFO Patel Snehal, dated Jul 28, 2026, worth $20K.
- Industry:Biotechnology
- CEO:Snehal S. Patel
- Employees:13
- HQ:Stafford, TX, US
- IPO:2020-09-25
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CEO and CFO | Purchase | 1,500 | $20K | Jul 30 | +10.2% | SEC ↗ | |
| CEO and CFO | Purchase | 700 | $9K | Jul 30 | +10.2% | SEC ↗ | |
| CEO and CFO | Purchase | 1,500 | $20K | Jul 29 | +20.7% | SEC ↗ | |
Patel SnehalFirst in 6 months | CEO and CFO | Purchase | 2,500 | $33K | Jul 27 | +15.0% | SEC ↗ |
Patel SnehalFirst in 6 months | CEO and CFO | Purchase | 1,100 | $14K | Jul 27 | +15.0% | SEC ↗ |
| CEO and CFO | Purchase | 1,800 | $54K | Jan 15 | -43.2% | SEC ↗ | |
| CEO and CFO | Purchase | 2,900 | $80K | Jan 14 | -47.3% | SEC ↗ | |
| CEO and CFO | Purchase | 4,300 | $92K | Jan 5 | -27.2% | SEC ↗ | |
| CEO and CFO | Purchase | 2,900 | $63K | Jan 2 | -20.6% | SEC ↗ | |
| CEO and CFO | Purchase | 4,100 | $52K | Dec 19 | +18.8% | SEC ↗ | |
| CEO and CFO | Purchase | 4,600 | $39K | Nov 28 | — | SEC ↗ | |
| CEO and CFO | Purchase | 10,600 | $89K | Nov 12 | — | SEC ↗ | |
Patel SnehalFirst filing | CEO and CFO | Purchase | 2,300 | $21K | Nov 4 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does GLSI have?
Greenwich LifeSciences, Inc. (GLSI) has 11 SEC Form 4 filings (13 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jul 30, 2026.
When was the most recent SEC Form 4 filing for GLSI?
The most recent Form 4 filing for GLSI on Tracefour is dated Jul 30, 2026.
Who is the most active insider at GLSI?
The most active SEC Form 4 filer at GLSI in the rolling window is CEO and CFO Patel Snehal, with 13 filings.
What is the net insider flow at GLSI over the last 6 months?
Over the trailing 180 days, insiders at GLSI have net bought $97K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at GLSI in the current window?
Inside the rolling window, insiders at GLSI bought $586K and sold $0 based on SEC Form 4 filings.
Can I get alerts for GLSI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Greenwich LifeSciences, Inc. (GLSI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Greenwich LifeSciences, Inc. is in the Healthcare sector.